Thanks for your comment! There were two main factors that led me to research this topic. Firstly, I wanted to be a part of an undergraduate research project relating to biochemistry and organic synthesis. I wanted to help improve my research skills for graduate school. Secondly, my younger sister used to suffer from a genetic heart condition. Anything related to the heart or cardiovascular system is really important to me since I saw her go through a lot with her heart condition. Therefore, when given the opportunity to work on this research project, I had a personal reason to want to do research on a topic that could potentially, in the future, help those suffering from coronary heart disease.
Wow Shelby, this is so cool! Of the four directions you plan on going in the future, which one do you think will most likely cause the uniform shape you are going for? And what is the value of these nanoparticles being the same size?
Thanks for the comment! I think increasing the ratio of catalyst:monomer along with recalibrating the GPC will help the peptide-polymers to form a more uniform shape and make it easier to control the polymerization. In Table 1 in my PowerPoint slide, I have the ratios of desired and actual size of the polymers listed. A lot of the ratios are around 1.0-5.0, which is acceptable. However, some of the ratios are 10 or above, which is why more studies will need to be conducted to help better control the rate of polymerization.
The amount of ways our body chemically breaks down particles is incredible!
I hope your work can advance how we store and implement new medical treatments that can save more people.
Hi Representative Lynn! Thank you for taking the time to watch my presentation, I appreciate it. I first plan on attending graduate school for biochemistry at KSU. After that, I hope to work at a pharmaceutical company in the KC Metro area.
What motivated you to research this topic?
Thanks for your comment! There were two main factors that led me to research this topic. Firstly, I wanted to be a part of an undergraduate research project relating to biochemistry and organic synthesis. I wanted to help improve my research skills for graduate school. Secondly, my younger sister used to suffer from a genetic heart condition. Anything related to the heart or cardiovascular system is really important to me since I saw her go through a lot with her heart condition. Therefore, when given the opportunity to work on this research project, I had a personal reason to want to do research on a topic that could potentially, in the future, help those suffering from coronary heart disease.
Wow Shelby, this is so cool! Of the four directions you plan on going in the future, which one do you think will most likely cause the uniform shape you are going for? And what is the value of these nanoparticles being the same size?
Thanks for the comment! I think increasing the ratio of catalyst:monomer along with recalibrating the GPC will help the peptide-polymers to form a more uniform shape and make it easier to control the polymerization. In Table 1 in my PowerPoint slide, I have the ratios of desired and actual size of the polymers listed. A lot of the ratios are around 1.0-5.0, which is acceptable. However, some of the ratios are 10 or above, which is why more studies will need to be conducted to help better control the rate of polymerization.
Interesting work. Great job walking through your project!
Thank you for your work and sharing it with us.
Shelby, nice work. Listening to your presentation gives me a sense of security knowing our future is good hands. Keep it up!
The amount of ways our body chemically breaks down particles is incredible!
I hope your work can advance how we store and implement new medical treatments that can save more people.
Nicely done! What are your professional plans for your future? Keep up the great work!
Hi Representative Lynn! Thank you for taking the time to watch my presentation, I appreciate it. I first plan on attending graduate school for biochemistry at KSU. After that, I hope to work at a pharmaceutical company in the KC Metro area.